Go Pro
→ They laughed at the baby-faced broker (*but shouldn’t have!) (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
$0.00
$0.00
$0.51
▼
$2.05
$111KN/A136,653 shs1,000 shs
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
$0.00
$0.03
$0.00
▼
$0.64
$2K1.5729,651 shsN/A
VGLS
VG Life Sciences
$0.48
$0.40
$0.03
▼
$2.25
$510K1.199,362 shs4 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$0.21
-5.8%		$0.24
$0.21
▼
$2.80
$374K0.42,596 shs16,067 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00%0.00%0.00%0.00%0.00%
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
0.00%-98.47%+150.00%-99.52%-99.92%
VGLS
VG Life Sciences
+17.02%-4.04%+6.62%+19.95%+479,700.00%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00%0.00%+5.19%-34.41%-90.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
$0.00
$0.00
$0.51
▼
$2.05
$111KN/A136,653 shs1,000 shs
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
$0.00
$0.03
$0.00
▼
$0.64
$2K1.5729,651 shsN/A
VGLS
VG Life Sciences
$0.48
$0.40
$0.03
▼
$2.25
$510K1.199,362 shs4 shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$0.21
-5.8%		$0.24
$0.21
▼
$2.80
$374K0.42,596 shs16,067 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00%0.00%0.00%0.00%0.00%
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
0.00%-98.47%+150.00%-99.52%-99.92%
VGLS
VG Life Sciences
+17.02%-4.04%+6.62%+19.95%+479,700.00%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00%0.00%+5.19%-34.41%-90.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00
N/AN/AN/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
0.00
N/AN/AN/A
VGLS
VG Life Sciences
0.00
N/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/AN/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
$536.36K0.00N/AN/A$1.59 per share0.00
VGLS
VG Life Sciences
N/AN/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$1.05M0.36N/AN/A($6.77) per share-0.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
-$5.02M-$2.42N/AN/AN/A-988.83%-224.08%-172.88%N/A
VGLS
VG Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-$10.37M-$3.49N/AN/AN/A-682.67%N/A-261.90%N/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
N/AN/AN/AN/AN/A
VGLS
VG Life Sciences
N/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
N/A
6.21
6.21
VGLS
VG Life Sciences
N/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/A
0.47
0.30

Institutional Ownership

CompanyInstitutional Ownership
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
74.31%
VGLS
VG Life Sciences
N/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
24.22%

Insider Ownership

CompanyInsider Ownership
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
32.11%
VGLS
VG Life Sciences
N/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A55.66 millionN/ANot Optionable
Lipella Pharmaceuticals Inc. stock logo
LIPO
Lipella Pharmaceuticals
44.62 million3.03 millionNot Optionable
VGLS
VG Life Sciences
11.06 millionN/ANot Optionable
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
141.78 million1.27 millionN/A

Recent News About These Companies

Longevity Health Raises Capital via Secured Convertible Note
September 4 at 5:51 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/longevity-health-raises-capital-via-secured-convertible-note?utm_source=marketbeat.com&utm_medium=referral
Longevity Health Holdings Announces Settlement of Litigation with Puritan Partners LLC
August 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3346173/0/en/longevity-health-holdings-announces-settlement-of-litigation-with-puritan-partners-llc.html
Longevity Health Announces Routine Board Member Resignation
June 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/longevity-health-announces-routine-board-member-resignation?utm_source=marketbeat.com&utm_medium=referral
Head to Head Contrast: Longevity Health (NASDAQ:XAGE) & Biosig Technologies (NASDAQ:STEX)
March 27, 2026  |  defenseworld.netD
Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
March 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/17/3257196/0/en/longevity-health-holdings-closes-strategic-investment-and-appoints-ram-ajjarapu-as-chairman-and-ceo-to-drive-acquisition-focused-growth.html
Longevity Health Holdings Ends Merger with True Health
December 12, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/longevity-health-holdings-ends-merger-with-true-health?utm_source=marketbeat.com&utm_medium=referral
Why Longevity Health Stock Is Skyrocketing Today
July 15, 2025  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/25/07/46430331/why-longevity-health-stock-is-skyrocketing-today
Why Longevity Health Stock Is Skyrocketing Today
July 15, 2025  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/25/07/46430331/why-longevity-health-stock-is-skyrocketing-today?utm_source=snapi
Why did XAGE Stock Surge in Today’s Premarket Trading?
July 15, 2025  |  tokenist.comT
Longevity Health Holdings, Inc.: Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
July 15, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65907064-longevity-health-holdings-inc-longevity-health-holdings-announces-merger-with-thplasma-and-termination-of-20-20-biolabs-transaction-399.htm
Longevity Health Holdings to Merge With True Health
July 15, 2025  |  marketwatch.comhttps://www.marketwatch.com/story/longevity-health-holdings-to-merge-with-true-health-5632aee0
Longevity Health stock soars after merger with THPlasma in all-stock deal
July 15, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/longevity-health-stock-soars-after-merger-with-thplasma-in-allstock-deal-93CH-4135554
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
July 14, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/07/14/3115204/0/en/Longevity-Health-Holdings-Announces-Merger-with-THPlasma-and-Termination-of-20-20-BioLabs-Transaction.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
The Metals Company logo displayed over an image of polymetallic nodules on the seafloor with sea stars.
The Metals Company’s Big Bet Now Comes Down to a License
By Thomas Hughes | August 16, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Belden logo displayed with networking cables, connectors, and server hardware in a dark data center setting.
The AI Boom Is Turning This Cable Maker Into a Stock to Watch
By Peter Frank | August 18, 2026
Illustration of an upward-trending stock chart line overlaid on a city skyline of office towers at sunset.
Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
By Nathan Reiff | August 30, 2026
Asterias Biotherapeutics stock logo

Asterias Biotherapeutics NYSEAMERICAN:AST

$0.0020 0.00 (0.00%)
As of 07/10/2019

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.

Lipella Pharmaceuticals stock logo

Lipella Pharmaceuticals NASDAQ:LIPO

$0.0005 0.00 (0.00%)
As of 09/3/2026

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

VG Life Sciences OTCMKTS:VGLS

$0.48 0.00 (0.00%)
As of 09/3/2026

VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.

Longevity Health stock logo

Longevity Health NASDAQ:XAGE

$0.21 -0.01 (-5.83%)
As of 11:26 AM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas